[1]徐莉.羟考酮复合右美托咪定在腹腔镜全子宫切除术后镇痛中的应用[J].中国计划生育和妇产科,2018,(10):59-61.
　XU Li.Application of oxycodone combined with dexmedetomidine in analgesia after laparoscopic hysterectomy[J].Chinese Journal of Family Planning & Gynecotokology,2018,(10):59-61.
点击复制

羟考酮复合右美托咪定在腹腔镜全子宫切除术后镇痛中的应用
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2018年10期
页码:
59-61
栏目:
论著与临床
出版日期:
2018-10-25

文章信息/Info

Title:
Application of oxycodone combined with dexmedetomidine in analgesia after laparoscopic hysterectomy
作者:
徐莉
成都市妇女儿童中心医院麻醉科
Author(s):
XU Li
Department of Anesthesiology,Chengdu Women and Children Central Hospital,Chengdu Sichuan 610099,P.R.China
关键词:
羟考酮; 右美托咪定; 术后镇痛
Keywords:
oxycodone; dexmedetomidine; postoperative analgesia
分类号:
R 619
摘要:
目的观察羟考酮复合右美托咪定用于腹腔镜全子宫切除术术后镇痛的安全性和有效性。方法回顾性分析2015年1月至2016年1月在成都市妇女儿童中心医院的60例全麻下行腹腔镜全子宫切除术患者的临床资料，按照术后用药方法不同分为两组，每组30例，羟考酮复合右美托咪定组为QD组，仅用羟考酮组为Q组，QD组术后镇痛采用羟考酮20 mg复合右美托咪定15 μg/kg,Q组采用羟考酮30 mg，分析术后2、8和24 h 疼痛视觉模拟（visual analog scales，VAS）评分、Ramsay镇静评分；记录补救性镇痛药羟考酮的患者数；比较两组镇痛满意度以及不良反应。结果两组术后2、8和24 h VAS评分、Ramsay镇静评分比较差异均无统计学意义（P＞005），QD组患者镇痛满意度高于Q组（P＜005），QD组恶心、呕吐发生率和头晕嗜睡发生率低于Q组（P＜005）。结论羟考酮复合右美托咪定15 μg/kg用于腹腔镜全子宫切除术后镇痛减少了羟考酮的用药量，降低了恶心、呕吐和头晕的发生率，镇痛满意度高。
Abstract:
ObjectiveTo observe the safety and efficacy of oxycodone combined with dexmedetomidine for postoperative analgesia after laparoscopic hysterectomy. Methods60 patients scheduled for laparoscopic hysterectomy surgeries under general anesthesia from January 2015 to January 2016 in Chengdu Women and Children Central Hospital were divided into oxycodone combined with dexmedetomidine group (group QD) and oxycodone group(group Q) according to different methods of medication after operation. The postoperative analgesia in the QD group was treated with oxycodone 20 mg and dexmedetomidine 15 μg/kg. The Q group was treated with oxycodone 30 mg. The VAS score and Ramsay sedation score were analyzed at 2, 8 and 24 h after surgery. The number of patients with the salvage analgesic oxycodone was recorded; the analgesic satisfaction and adverse reactions were compared. ResultsThere were no significant differences in VAS scores and Ramsay sedation scores between the two groups at 2, 8 and 24 h after surgery. The analgesic satisfaction of the QD group was higher than that of the Q group (P<005). The incidence of nausea, vomiting, dizziness and drowsiness in the QD group was lower than those of the Q group (P<005). ConclusionCompound dexmedetomidine 1.5 μg/kg for analgesia after laparoscopic hysterectomy can reduce the dose of oxycodone, the incidence of nausea, vomiting and dizziness with high satisfaction.

参考文献/References:

［1］黄凌，黎惠芳，马冬．羟考酮口服片剂治疗癌症爆发痛的治疗策略 ［J］．实用医学杂志，2009，25（15）：2554-2556． ［2］陈炳权．围手术期羟考酮临床应用进展 ［J］．中外医疗，2015（29）：195-198． ［3］王琳，徐铭军，魏江．超声引导腹横肌平面阻滞对剖宫产术后镇痛的影响 ［J］．临床麻醉学杂志，2016，32（7）：661-664． ［4］刘伟，陈高峰，岳生，等．右美托咪定复合不同剂量舒芬太尼对脊柱手术患者术后镇痛的影响 ［J］．临床麻醉学杂志，2016，32（3）：265-267． ［5］徐建国．盐酸羟考酮的药理学和临床应用 ［J］．临床麻醉学杂志，2014，30（5）：511-513． ［6］HWANG B Y, KWON J Y, KIM E, et al. Oxycodone vs. fentanyl patient-controlled analgesia after laparoscopic cholecystectomy ［J］. International Journal of Medical Sciences, 2014, 11 (7): 658-662. ［7］LENZ H, SANDVIK L, QVIGSTAD E, et al. A comparison of intravenous oxycodone and intravenous morphine in patient-controlled postoperative analgesia after laparoscopic hysterectomy ［J］. Anesthesia and Analgesia, 2009, 109 (4): 1279-1283. ［8］王宇，崔宇，刘国奕，等．羟考酮和舒芬太尼在腹腔镜胆囊切除术后静脉自控镇痛的比较 ［J］．实用医学杂志，2016，32（12）：2045-2047． ［9］林莹，陈彦青，戴双波．舒芬太尼复合右美托咪定妇科腔镜手术术后镇痛效果观察 ［J］．临床麻醉学杂志，2011，27（7）：690-692．

相似文献/References:

[1]韩坤,唐勇,周乐,等.羟考酮无背景剂量自控静脉镇痛在剖宫产术后镇痛中的应用[J].中国计划生育和妇产科,2019,(2):55.
　HAN Kun,TANG Yong,ZHOU Le,et al.Application of no background patient-controlled intravenous analgesia with oxycodone in analgesia after cesarean section[J].Chinese Journal of Family Planning & Gynecotokology,2019,(10):55.
[2]唐勇,潘雪琳*,刘庆.右美托咪定复合罗哌卡因程控硬膜外间歇脉冲注入应用于分娩镇痛的临床研究[J].中国计划生育和妇产科,2019,(8):53.
　TANG Yong,PAN Xue-lin*,LIU Qing.Clinical study of dexmedetomidine combined with ropivacaine programmed intermittent epidural bolus for labor analgesia[J].Chinese Journal of Family Planning & Gynecotokology,2019,(10):53.

更新日期/Last Update: 2018-10-25